VM

VHCP Management Portfolio holdings

AUM $93M
1-Year Est. Return 10.46%
This Quarter Est. Return
1 Year Est. Return
-10.46%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$102M
AUM Growth
+$5.19M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$2.6M
2
+$1.46M
3
+$267K
4
OCRX
Ocera Therapeutics, Inc.
OCRX
+$158K
5
ARCT icon
Arcturus Therapeutics
ARCT
+$87.9K

Top Sells

1
+$8.18M
2
+$1.21M
3
+$397K

Sector Composition

1 Healthcare 65.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$236M
$18.9M 18.57%
1,095,734
CHRS icon
2
Coherus Oncology
CHRS
$192M
$8.18M 8.05%
305,505
-305,505
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.48B
$6.2M 6.1%
500,000
ADVM icon
4
Adverum Biotechnologies
ADVM
$90M
$4.53M 4.46%
110,274
BCRX icon
5
BioCryst Pharmaceuticals
BCRX
$1.4B
$4.43M 4.36%
1,005,104
LPCN icon
6
Lipocine
LPCN
$16.4M
$3.79M 3.73%
49,995
CLCD
7
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$2.6M 2.56%
+68,190
SIOX
8
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.58M 2.54%
23,014
OCRX
9
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.26M 2.22%
856,550
+60,000
LRMR icon
10
Larimar Therapeutics
LRMR
$359M
$1.99M 1.96%
50,176
ASND icon
11
Ascendis Pharma
ASND
$12.7B
$1.81M 1.78%
90,000
ARCT icon
12
Arcturus Therapeutics
ARCT
$561M
$1.63M 1.6%
94,130
+5,085
ONC
13
BeOne Medicines Ltd
ONC
$34.8B
$1.57M 1.54%
51,000
STML
14
DELISTED
Stemline Therapeutics, Inc.
STML
$1.47M 1.44%
135,420
ACHN
15
DELISTED
Achillion Pharmaceuticals
ACHN
$1.46M 1.43%
+180,000
PDSB icon
16
PDS Biotechnology
PDSB
$43.6M
$1.41M 1.38%
6,750
AKTX
17
Akari Therapeutics
AKTX
$26.1M
$1.35M 1.33%
7,918
ORKA
18
Oruka Therapeutics
ORKA
$1.33B
$1.31M 1.29%
2,141
CTMX icon
19
CytomX Therapeutics
CTMX
$528M
$1.01M 0.99%
64,200
RGNX icon
20
Regenxbio
RGNX
$593M
$337K 0.33%
24,089
-28,411
BOLD
21
DELISTED
Audentes Therapeutics, Inc
BOLD
$267K 0.26%
+15,000
SRRA
22
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$102K 0.1%
1,401
SYRE icon
23
Spyre Therapeutics
SYRE
$1.74B
$38K 0.04%
240
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-72,990